GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,533,000 | +2164.7% | 81,155 | +2138.8% | 0.01% | – |
| Q1 2022 | $156,000 | -0.6% | 3,625 | +1.3% | 0.00% | – |
| Q4 2021 | $157,000 | +15.4% | 3,580 | +3.1% | 0.00% | – |
| Q3 2021 | $136,000 | +0.7% | 3,471 | +2.0% | 0.00% | – |
| Q2 2021 | $135,000 | +11.6% | 3,402 | 0.0% | 0.00% | – |
| Q1 2021 | $121,000 | -98.1% | 3,402 | -98.0% | 0.00% | -100.0% |
| Q4 2020 | $6,287,000 | -1.4% | 169,200 | 0.0% | 0.02% | -11.8% |
| Q3 2020 | $6,378,000 | -8.2% | 169,200 | -0.0% | 0.02% | -19.0% |
| Q2 2020 | $6,951,000 | +8.5% | 169,215 | +0.0% | 0.02% | -8.7% |
| Q1 2020 | $6,406,000 | -20.0% | 169,200 | 0.0% | 0.02% | -4.2% |
| Q4 2019 | $8,011,000 | +11.7% | 169,200 | -0.2% | 0.02% | +4.3% |
| Q3 2019 | $7,173,000 | +6.0% | 169,481 | +0.1% | 0.02% | +4.5% |
| Q2 2019 | $6,766,000 | +22453.3% | 169,288 | +23576.6% | 0.02% | – |
| Q1 2019 | $30,000 | -18.9% | 715 | -26.1% | 0.00% | – |
| Q4 2018 | $37,000 | +27.6% | 967 | +35.2% | 0.00% | – |
| Q3 2018 | $29,000 | -12.1% | 715 | -12.5% | 0.00% | – |
| Q2 2018 | $33,000 | +17.9% | 817 | +14.3% | 0.00% | – |
| Q1 2018 | $28,000 | -93.5% | 715 | -94.1% | 0.00% | -100.0% |
| Q4 2017 | $428,000 | -58.1% | 12,115 | -53.3% | 0.00% | -75.0% |
| Q3 2017 | $1,021,000 | +7.9% | 25,915 | +18.3% | 0.00% | 0.0% |
| Q2 2017 | $946,000 | +3053.3% | 21,915 | +2965.0% | 0.00% | – |
| Q1 2017 | $30,000 | -99.7% | 715 | -99.8% | 0.00% | -100.0% |
| Q4 2016 | $10,096,000 | +466.6% | 361,604 | +775.2% | 0.02% | +142.9% |
| Q3 2016 | $1,782,000 | -15.0% | 41,315 | -14.0% | 0.01% | -12.5% |
| Q2 2016 | $2,096,000 | -40.8% | 48,040 | -7.9% | 0.01% | -11.1% |
| Q1 2016 | $3,539,000 | +56.0% | 52,140 | -5.4% | 0.01% | -10.0% |
| Q4 2015 | $2,269,000 | +18.2% | 55,140 | +10.9% | 0.01% | +25.0% |
| Q3 2015 | $1,919,000 | +17.6% | 49,715 | +26.8% | 0.01% | +33.3% |
| Q2 2015 | $1,632,000 | +4700.0% | 39,215 | +5271.9% | 0.01% | – |
| Q1 2015 | $34,000 | 0.0% | 730 | -8.8% | 0.00% | – |
| Q4 2014 | $34,000 | +6.2% | 800 | +14.3% | 0.00% | – |
| Q3 2014 | $32,000 | -13.5% | 700 | 0.0% | 0.00% | – |
| Q2 2014 | $37,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q1 2014 | $37,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |